Kymera Therapeutics (KYMR) CMO Rooney Terence files insider Form 3
Rhea-AI Filing Summary
Kymera Therapeutics, Inc. filed an initial statement of beneficial ownership on Form 3 for Rooney Terence, who serves as Chief Medical Officer. This establishes him as a reporting officer under SEC rules and references an Exhibit 24 Power of Attorney relating to SEC filing authorizations.
Positive
- None.
Negative
- None.
Key Figures
Buy transactions reported: 0
Sell transactions reported: 0
2 metrics
Buy transactions reported
0
Total number of buy transactions in this Form 3
Sell transactions reported
0
Total number of sell transactions in this Form 3
Key Terms
Form 3, Power of Attorney, beneficial ownership
3 terms
Form 3 regulatory
"Filed as an initial statement of beneficial ownership on Form 3"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Power of Attorney regulatory
"Remarks reference Exhibit 24 - Power of Attorney for SEC filings"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
beneficial ownership financial
"Initial statement of beneficial ownership on Form 3 for the officer"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the KYMR Form 3 filed for Rooney Terence represent?
The filing is an initial Form 3 statement of beneficial ownership for Rooney Terence as an officer of Kymera Therapeutics. It formally identifies him as a reporting person subject to SEC insider reporting requirements for future transactions in the company’s securities.
What position does Rooney Terence hold at Kymera Therapeutics (KYMR)?
Rooney Terence is reported as the Chief Medical Officer of Kymera Therapeutics, Inc. This officer title is disclosed in the Form 3 and is the basis for his status as a reporting person under SEC insider ownership and transaction reporting rules.
Does the KYMR Form 3 for Rooney Terence report any insider trades?
No, the Form 3 for Rooney Terence reports no buy or sell transactions. The structured data show zero buy and sell counts, indicating the filing serves as an initial ownership statement rather than a record of recent trading activity in Kymera’s securities.
Is Rooney Terence a 10% owner of Kymera Therapeutics (KYMR) in this filing?
Rooney Terence is not reported as a 10% owner of Kymera Therapeutics, Inc. The Form 3 data indicate the ten-percent-owner status box is not marked, while he is identified as an officer in his capacity as Chief Medical Officer.
What is Exhibit 24 in Kymera Therapeutics (KYMR) Chief Medical Officer’s Form 3?
The remarks reference Exhibit 24 – Power of Attorney. This exhibit typically authorizes designated individuals to sign and submit SEC filings on the reporting person’s behalf, streamlining future reporting obligations for the officer named in the Form 3.